Cargando…
Targeting IL-6 by both passive or active immunization strategies prevents bleomycin-induced skin fibrosis
INTRODUCTION: Interleukin-6 (IL-6) is a pleiotropic cytokine for which preliminary data have suggested that it might contribute to systemic sclerosis (SSc). Our aims were to investigate, firstly, IL-6 expression in patients with SSc and, secondly, the efficacy of both passive and active immunization...
Autores principales: | Desallais, Lucille, Avouac, Jérôme, Fréchet, Maxime, Elhai, Muriel, Ratsimandresy, Rojo, Montes, Matthieu, Mouhsine, Hadley, Do, Hervé, Zagury, Jean-François, Allanore, Yannick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220089/ https://www.ncbi.nlm.nih.gov/pubmed/25059342 http://dx.doi.org/10.1186/ar4672 |
Ejemplares similares
-
Immunization against an IL-6 peptide induces anti-IL-6 antibodies and modulates the Delayed-Type Hypersensitivity reaction in cynomolgus monkeys
por: Desallais, Lucille, et al.
Publicado: (2016) -
Combined effect of genetic background and gender in a mouse model of bleomycin-induced skin fibrosis
por: Ruzehaji, Nadira, et al.
Publicado: (2015) -
Retraction Note: Combined effect of genetic background and gender in a mouse model of bleomycin-induced skin fibrosis
por: Ruzehaji, Nadira, et al.
Publicado: (2023) -
Identification of an in vivo orally active dual-binding protein-protein interaction inhibitor targeting TNFα through combined in silico/in vitro/in vivo screening
por: Mouhsine, Hadley, et al.
Publicado: (2017) -
Linking systemic angiogenic markers to synovial vascularization in rheumatoid arthritis
por: Leblond, Agathe, et al.
Publicado: (2018)